Inhalable drug given green light

News

Author: Simge Eva DoganPublished: 9 January 2019

Prep: Cook: Serves:

The US Food and Drug Administration (FDA) has approved INBRIJA – an inhalable drug created by US biotech company Acorda Therapeutics – for intermittent treatment.

INBRIJA is designed to treat Parkinson’s symptoms that occur between oral doses of medication, which are known as ‘off’ episodes. The drug has been approved by the FDA and – after a clinical study involving 900 people with Parkinson’s – is expected to be available in 2019.

Todd Sherer, CEO of The Michael J Fox Foundation, who funded early trials of the powder, said: “Despite being on treatment, patients may experience OFF periods as Parkinson’s progresses, which can be disruptive.

“We knew we had to help address this unmet need, and this approval is a significant step forward for the community as it provides a new option to manage these gaps in symptom control.”

To read more on this topic click here.

For more information on Parkinson’s medication please visit the EPDA website.

Memory loss could be an indication of Parkinson’s

Last Month

Next Month

Go Back

Share this story

Comments

Perspectives

Diana Levine: taking photos for a cure

An interview with Parkinson’s campaigner and photographer Diana Levine

Caring and sharing – the importance of learning to let it out

Why good communication is essential in families affected by Parkinson's

Who said what: 4 powerful Parkinson’s quotes we loved this week

Our favourite quotes of the week from around the web

Stay tuned for series two of the Parkinson’s Life podcast

The award-winning Parkinson’s Life podcast is back this month. Helping to amplify the voices of the international Parkinson’s community, the podcast has so far reached more than 12,000 people around the world. Thanks to the support of pharmaceutical companies, and the backing of a grant from the Boston Scientific Foundation Europe, the second series will bring together people with Parkinson’s disease and experts in their field to explore topics such as sleep hygiene, exercise and mental health, and to offer advice to listeners. Sandrine Bazile, president of the Boston Scientific Foundation Europe, says: “We fully support this project because it mirrors perfectly our mission to improve patient wellbeing using innovative solutions. We believe in the importance of the [Parkinson’s Life] podcast series, with its aim to improve the information and education available to people with Parkinson’s and their families – to help them live life to the full.”

How Parkinson’s disease could impact the way you see art

A new study from a team at the University of Pennsylvania’s Perelman School of Medicine, US, has indicated that Parkinson’s disease could affect the way people experience art. The researchers asked 43 people with the condition and 40 controls to make judgements about 10 paintings by American artist Jackson Pollock and 10 by Dutch painter Piet Mondrian, rating them according to factors including liking, beauty, motion, complexity and colour-saturation. The participants with Parkinson’s showed more of a preference for ‘high-motion’ art. They also showed a lower recognition of movement compared to controls, suggesting that the brain’s motor system may help interpret movement from static visual cues. However, the research team noted that many of the participants were on their usual medication, and that the impact of dopamine agonists on the experience of art would also need to be considered.

Neuroticism may increase risk of Parkinson’s disease, research finds

Researchers at Florida State University, US, have found that neuroticism – a personality trait that affects how people experience negative emotions – is associated with a higher risk of developing Parkinson’s disease. The scientists analysed data collected by biomedical database UK Biobank on nearly 500,000 participants aged 40 to 69. Using health records to determine the incidence of Parkinson’s disease in these participants, they found that those who scored in the top quartile of neuroticism were 80% more at risk of developing Parkinson’s than those who scored lower. Antonio Terracciano, lead researcher of the study, said: “Our findings suggest that some emotional vulnerability is present early in life, years before the development of Parkinson’s disease. It kind of gives you a better understanding of the risk factors for the disease and what could be a contributing cause […] The evidence is convincing.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Email
This field is for validation purposes and should be left unchanged.

Inhalable drug given green light

News

Author: Simge Eva DoganPublished: 9 January 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Perspectives

Diana Levine: taking photos for a cure

Health & Fitness

Caring and sharing – the importance of learning to let it out

Perspectives

Who said what: 4 powerful Parkinson’s quotes we loved this week

Stay tuned for series two of the Parkinson’s Life podcast

How Parkinson’s disease could impact the way you see art

Neuroticism may increase risk of Parkinson’s disease, research finds

{title}

Subscribe

Inhalable drug given green light

News

Author: Simge Eva DoganPublished: 9 January 2019

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Perspectives

Diana Levine: taking photos for a cure

Health & Fitness

Caring and sharing – the importance of learning to let it out

Perspectives

Who said what: 4 powerful Parkinson’s quotes we loved this week

Stay tuned for series two of the Parkinson’s Life podcast

How Parkinson’s disease could impact the way you see art

Neuroticism may increase risk of Parkinson’s disease, research finds

{title}

Subscribe

Sign in